financetom
Business
financetom
/
Business
/
MCF Energy Unchanged After Providing Germany Operations Update
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MCF Energy Unchanged After Providing Germany Operations Update
Dec 10, 2024 7:18 AM

09:48 AM EST, 12/10/2024 (MT Newswires) -- MCF Energy ( MCFNF ) , near 52-week lows, was at last look unchanged in early Tuesday trade after it overnight Monday provided an update on its Reudnitz Gas field testing and development operations and wellsite preparation for the Kinsau-1A well at Lech, Germany.

The company in a statement said Reudnitz gas field testing and development operations are continuing. Phase 1 testing was completed, and Phase 2 plans were submitted to the German mining authority, Laufzeit der Erlaubnis zur Aufsuchung (LNGR). Phase 2 will involve additional stimulation and testing on the Reudnitz RZ2 horizontal well to improve production rates.

MCF said it received the approval of a nine-month extension of the Reudnitz Exploration Licence by the LNGR with the new expiration date of Sept. 30, 2025.

Genexco GmbH (100% owned by MCF) holds a 100% interest in the Reudnitz RZ2 gas discovery well on the Reudnitz Exploration Licence

"Following Phase 2 testing Genexco will submit an application for a production licence. There is good progress in Lech with the construction of the Kinsau-1A drill site, which continues to be on schedule with the well expected to spud in Q1 of 2025," said MCF Energy ( MCFNF ) chief executive officer and director James Hill.

Shares of the company were flat at $0.055 at last close on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Basilea Pharmaceutica's antibiotic
US FDA approves Basilea Pharmaceutica's antibiotic
Apr 3, 2024
(Reuters) -The U.S. health regulator approved Basilea Pharmaceutica's antibiotic for bacterial infections including multidrug-resistant strains, the FDA said on Wednesday. The Switzerland-based company was seeking approval of its antibiotic ceftobiprole for the treatment of three conditions - Staphylococcus aureus bacteremia (SAB) as well as acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia. The approval expands options for...
Dropbox Insider Sold Shares Worth $1,991,550, According to a Recent SEC Filing
Dropbox Insider Sold Shares Worth $1,991,550, According to a Recent SEC Filing
Apr 3, 2024
04:06 PM EDT, 04/03/2024 (MT Newswires) -- Andrew Houston, 10% Owner, Director, Chief Executive Officer, on April 01, 2024, sold 82,000 shares in Dropbox ( DBX ) for $1,991,550. Following the Form 4 filing with the SEC, Houston has control over a total of 9,427,838 shares of the company, with 8,266,666 shares held directly and 1,161,172 controlled indirectly. SEC Filing:...
Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing
Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing
Apr 3, 2024
04:06 PM EDT, 04/03/2024 (MT Newswires) -- Nassim Usman, Director, on April 01, 2024, sold 20,000 shares in Gyre Therapeutics ( GYRE ) for $323,000. Following the Form 4 filing with the SEC, Usman has control over a total of 2,276 shares of the company, with 1,636 shares held directly and 640 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1124105/000114036124017566/xslF345X03/form4.xml ...
Cvd Equipment Insider Bought Shares Worth $1,084,162, According to a Recent SEC Filing
Cvd Equipment Insider Bought Shares Worth $1,084,162, According to a Recent SEC Filing
Apr 3, 2024
04:06 PM EDT, 04/03/2024 (MT Newswires) -- Andrew Africk, 10% Owner, on April 01, 2024, executed a purchase for 217,554 shares in Cvd Equipment ( CVV ) for $1,084,162. Following the Form 4 filing with the SEC, Africk has control over a total of 1,248,082 shares of the company, with 1,248,082 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/766792/000110465924043084/xslF345X03/tm2410979-1_4seq1.xml Price: 6.13, Change: +0.32,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved